ImmunityBio (IBRX) Goodwill (2024 - 2026)
ImmunityBio's (IBRX) quarterly Goodwill came in at $910000.0 in Q1 2026, little changed year-on-year from $910000.0 in Q1 2025, and little changed on a QoQ basis from $910000.0 in Q4 2025.
ImmunityBio (IBRX) Goodwill (2024 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 3 years of Goodwill data on file, last reported at $910000.0 in Q1 2026.
- On a quarterly basis, Goodwill changed 0.0% year-over-year to $910000.0 in Q1 2026; TTM through Mar 2026 was $910000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $910000.0, changed 0.0% from the prior year.
- Goodwill for Q1 2026 stood at $910000.0, roughly flat from $910000.0 in the prior quarter.
- Over the last five years, Goodwill for IBRX reached as high as $910000.0 in Q4 2024 and fell as low as $900000.0 in Q3 2024.
- Historically, Goodwill has averaged $908571.4 across 3 years, with a median of $910000.0 in 2024.
- On a YoY basis, Goodwill climbed as much as 1.11% in 2025 and fell as far as 0.0% in 2025.
- Year by year, Goodwill stood at $910000.0 in 2024, then changed by 0.0% to $910000.0 in 2025, then changed by 0.0% to $910000.0 in 2026.
- Per Business Quant data, the three most recent Goodwill figures were $910000.0 in Q1 2026, $910000.0 in Q4 2025, and $910000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | ImmunityBio | 7.60 Bn | 7.22 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 910,000.00 |
| Dec 31, 2025 | 910,000.00 |
| Sep 30, 2025 | 910,000.00 |
| Jun 30, 2025 | 910,000.00 |
| Mar 31, 2025 | 910,000.00 |
| Dec 31, 2024 | 910,000.00 |
| Sep 30, 2024 | 900,000.00 |